Export 11 results:
Filters: Keyword is Immunosuppressive Agents/tu [Therapeutic Use] [Clear All Filters]
Multidrug-resistant bacteria in solid organ transplant recipients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases//Clin Microbiol Infect. 2014;20 Suppl 7:49-73.
Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area. Transplantation// Transplantation. 2014;97(1):e3-4.
Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease. The Journal of surgical research// J Surg Res. 2012;176(2):629-38.
Fulminant hepatitis following primary herpes simplex virus infection. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia//Saudi J Kidney Dis Transpl. 2011;22(1):107-11.
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation//J Heart Lung Transplant. 2010;29(9):1014-20.
Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment. Transfusion//Transfusion. 2010;50(2):429-32.
Infectious complications in three double hand recipients: experience from a single center. Transplantation proceedings//Transplant Proc. 2009;41(2):517-20.
Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center. Transfusion//Transfusion. 2003;43(12):1672-6.
Donor anti-Jk(a) causing hemolysis in a liver transplant recipient. Transfusion//Transfusion. 2002;42(3):363-7.
Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplantation proceedings//Transplant Proc. 1998;30(4):1324-6.